Abstract: A medical treatment apparatus generates moving cold and hot gas streams by supplying air having a low dew point (after being compressed, liquefied or dried subsequent to a compression step) to a vortex tube while the air cleanliness level thereof is improved by removal of oily substances and solid particles to negligible levels. The medical treatment apparatus most preferably includes a hand piece for medical treatment, a vortex tube and a retaining assembly which adjustably retains the vortex tube on said hand piece and allows for positional adjustment of the vortex tube relative to a medical treatment area. The retaining assembly includes a first retaining member attached to the vortex tube, and a second retaining member attached to the hand piece, with the first and second retaining members being pivotally connected to each other.

Abstract: A therapeutic pharmaceutical composition containing 3,4,5-trimethoxy-N-3-piperidylbenzamide (troxipide) as an active ingredient for gastritis in admixture with an inert pharmaceutical carrier. The composition may be administered orally in the forms of tablets, capsules, granules and fine granules.

Abstract: Urea derivatives of the following formula: ##STR1## wherein R.sub.2 indicates a piperidino or pyrrolidino group which may be substituted with a hydroxy group or a lower alkyl group having 1 to 13 carbon atoms; A indicates an ethylene group, propylene group, butylene group or butenylene group; R.sub.2 indicates a straight or branched alkyl group having 1 to 20 carbon atoms, a benzyl group, or a phenyl group which may have 1 to 3 substituents such as a lower alkyl group having 1 to 6 carbon atoms, a lower alkoxy group having 1 to 3 carbon atoms, a halogen atom, a trifluoromethyl group, an amino group, a nitro group or a methylenedioxy group; and X indicates an oxygen or sulfur atom, as well as the hydrates and pharmaceutically acceptable salts thereof are useful antiulcer agents.

Abstract: Urea derivatives of the following formula, ##STR1## wherein R.sub.1 indicates a piperidino group or pyrrolidino group which may be substituted with hydroxy group or lower alkyl group having 1 to 3 carbon atoms; A indicates an ethylene group, propylene group, butylene group or butenylene group; R.sub.2 indicates a straight or branched alkyl group having 1 to 20 carbon atoms, cycloalkyl group having 3 to 6 carbon atoms, benzyl group, or phenyl group which may have 1 to 3 substituents such as lower alkyl group having 1 to 6 carbon atoms, lower alkoxy group having 1 to 3 carbon atoms, halogen atom, trifluoromethyl group, amino group, nitro group or methylenedioxy group; X indicates an oxygen or sulfur atom, the hydrates and pharmaceutically acceptable acid addition salts thereof are useful as antiulcer agents.

Abstract: Disclosed herein is a process for producing ferromagnetic iron powder, which process comprises adding and mixing boron oxide or a borate with .alpha.-FeOOH or .alpha.-Fe.sub.2 O.sub.3 without dissolving the former, heating the thus-obtained mixture to 350.degree. C. or higher in a non-reducing atmosphere and then reducing the thus-heated mixture.

Abstract: Disclosed herein is a process for producing ferromagnetic iron powder, which process comprises adding and mixing zinc borate with .alpha.-FeOOH or .alpha.-Fe.sub.2 O.sub.3 without dissolving the former, heating the thus-obtained mixture to 350.degree. C. or higher in a non-reducing atmosphere and then reducing the thus-heated mixture.

Abstract: Disclosed is a process for preparing fine needle-like, ferromagnetic iron compound particles for use in magnetic recording in which needle-like iron oxyhydroxide fine particles prepared by simultaneously co-precipitating or cladding iron compound particles with an element of group II of the Periodic Table and manganese at atomic weight ratios of the element of group II of the Periodic Table and manganese to iron of from 0.001/100 to 10/100 and 0.005/100 to 10/100 respectively are reduced and/or oxidized under heating.